Showing results (281-290 of 389) with videos related to

Sort By:
Pageof 39
Drugs & Aging|November 10, 2018
Influenza Vaccination in Older Adults: Recent Innovations and Practical ApplicationsMelissa K Andrew, Susan K Bowles, Graham Pawelec, et al.
Gerontology|January 31, 2022
Muscle Mass and Inflammation in Older Adults: Impact of the Metabolic SyndromeNikolaus Buchmann, Jens Fielitz, Dominik Spira, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 27, 2014
CD4:8 ratio >5 is associated with a dominant naive T-cell phenotype and impaired physical functioning in CMV-seropositive very elderly people: results from the BELFRAIL studyWim Adriaensen, Evelyna Derhovanessian, Bert Vaes, et al.
BMC Immunology|September 24, 2013
Prothymosin α and a prothymosin α-derived peptide enhance T(H)1-type immune responses against defined HER-2/neu epitopesKyriaki Ioannou, Evelyna Derhovanessian, Eleni Tsakiri, et al.
Annals of the New York Academy of Sciences|November 8, 2007
Cytomegalovirus infection: a driving force in human T cell immunosenescenceSven Koch, Anis Larbi, Dennis Ozcelik, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 29, 2021
Cellular Immune Phenotypes and Worsening Scores of Frailty-Associated Parameters Over an 18-Month Period in the Very OldDavid Goldeck, Wim Adriaensen, Lilly Oettinger, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 9, 2015
CCR4+ Regulatory T Cells Accumulate in the Very Elderly and Correlate With Superior 8-Year SurvivalEvelyna Derhovanessian, Sijia Chen, Andrea B Maier, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 30, 2016
Cytomegalovirus Seropositivity Predicts a Decline in the T Cell But Not the Antibody Response to Influenza in Vaccinated Older Adults Independent of Type 2 Diabetes StatusKamran Haq, Tamas Fulop, Gale Tedder, et al.
Pageof 39